Franklin Resources Inc Gritstone Bio, Inc. Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.75 $612 - $1,182	249 Added 0.91%	27,567 $71,000
Q2 2022 Aug 11, 2022	SELL	$1.77 - $4.34 $23,611 - $57,895	-13,340 Reduced 32.81%	27,318 $66,000
Q1 2022 May 13, 2022	BUY	$4.03 - $12.19 $120 - $365	30 Added 0.07%	40,658 $167,000
Q4 2021 Feb 11, 2022	SELL	$8.76 - $13.71 $630 - $987	-72 Reduced 0.18%	40,628 $522,000
Q3 2021 Nov 12, 2021	BUY	$6.41 - $13.54 $260,887 - $551,078	40,700 New	40,700 $440,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.